Shell Asset Management’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-1,972
| Closed | -$105K | – | 1189 |
|
|
2025
Q2 | $105K | Buy |
1,972
+440
| +29% | +$22.4K | ﹤0.01% | 988 |
|
|
2025
Q1 | $66K | Hold |
1,532
| – | – | ﹤0.01% | 1095 |
|
|
2024
Q4 | $86K | Hold |
1,532
| – | – | ﹤0.01% | 1075 |
|
|
2024
Q3 | $104K | Buy |
+1,532
| New | +$86.5K | ﹤0.01% | 1042 |
|
|
2024
Q1 | $65K | Sell |
1,532
-1,485
| -49% | -$93.9K | ﹤0.01% | 1113 |
|
|
2023
Q4 | $223K | Sell |
3,017
-640
| -18% | -$41.9K | 0.01% | 814 |
|
|
2023
Q3 | $249K | Buy |
3,657
+146
| +4% | +$12.4K | 0.01% | 824 |
|
|
2023
Q2 | $330K | Buy |
3,511
+657
| +23% | +$51.3K | 0.01% | 750 |
|
|
2023
Q1 | $194K | Sell |
2,854
-107
| -4% | -$6.88K | 0.01% | 933 |
|
|
2022
Q4 | $147K | Sell |
2,961
-2,149
| -42% | -$87.8K | 0.01% | 1055 |
|
|
2022
Q3 | $166K | Hold |
5,110
| – | – | 0.01% | 1070 |
|
|
2022
Q2 | $201K | Buy |
5,110
+25
| +0.5% | +$1.34K | 0.01% | 1120 |
|
|
2022
Q1 | $356K | Buy |
5,085
+587
| +13% | +$42.9K | 0.01% | 971 |
|
|
2021
Q4 | $350K | Buy |
4,498
+1,430
| +47% | +$126K | 0.01% | 1055 |
|
|
2021
Q3 | $293K | Sell |
3,068
-415
| -12% | -$43.8K | 0.01% | 1087 |
|
|
2021
Q2 | $433K | Sell |
3,483
-1,205
| -26% | -$144K | 0.01% | 980 |
|
|
2021
Q1 | $618K | Buy |
4,688
+119
| +3% | +$16.3K | 0.01% | 759 |
|
|
2020
Q4 | $605K | Buy |
4,569
+580
| +15% | +$70.1K | 0.01% | 713 |
|
|
2020
Q3 | $407K | Hold |
3,989
| – | – | 0.01% | 770 |
|
|
2020
Q2 | $347K | Sell |
3,989
-763
| -16% | -$61K | 0.01% | 824 |
|
|
2020
Q1 | $276K | Sell |
4,752
-5,678
| -54% | -$461K | 0.01% | 902 |
|
|
2019
Q4 | $965K | Sell |
10,430
-19,232
| -65% | -$1.69M | 0.02% | 567 |
|
|
2019
Q3 | $2.68M | Buy |
29,662
+23
| +0.1% | +$2.62K | 0.06% | 307 |
|
|
2019
Q2 | $3.5M | Buy |
29,639
+7,319
| +33% | +$737K | 0.08% | 271 |
|
|
2019
Q1 | $1.93M | Buy |
22,320
+6,142
| +38% | +$523K | 0.04% | 360 |
|
|
2018
Q4 | $1.02M | Sell |
16,178
-4,063
| -20% | -$279K | 0.03% | 508 |
|
|
2018
Q3 | $1.6M | Hold |
20,241
| – | – | 0.03% | 453 |
|
|
2018
Q2 | $1.21M | Buy |
20,241
+5,166
| +34% | +$278K | 0.02% | 575 |
|
|
2018
Q1 | $608K | Hold |
15,075
| – | – | 0.01% | 848 |
|
|
2017
Q4 | $792K | Hold |
15,075
| – | – | 0.02% | 761 |
|
|
2017
Q3 | $710K | Sell |
15,075
-300
| -2% | -$12.1K | 0.02% | 734 |
|
|
2017
Q2 | $544K | Hold |
15,375
| – | – | 0.01% | 879 |
|
|
2017
Q1 | $363K | Buy |
+15,375
| New | +$305K | 0.01% | 970 |
|
Other funds holding EXAS
Shell Asset Management's EXAS Position: Q3 2025 in Review
Shell Asset Management sold out of Exact Sciences (EXAS) in Q3 2025, closing a stake of 1,972 shares — an estimated $105K sold.
Shell Asset Management first reported a position in EXAS in Q1 2017 and held it in 33 quarters. The position peaked at $3.5M in Q2 2019. 567 funds tracked by Wall St. Rank hold EXAS as of Q3 2025.
- Shell Asset Management reported no remaining Exact Sciences position as of Q3 2025 after selling out during the quarter.
- Shell Asset Management sold 1,972 Exact Sciences shares in Q3 2025, an estimated $105K.
- Shell Asset Management first reported a position in Exact Sciences in Q1 2017 and held it in 33 quarters.
- Shell Asset Management's Exact Sciences position peaked at $3.5M in Q2 2019.
- 567 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2025.
Based on Shell Asset Management's 13F filing for Q3 2025, filed 7 Nov 2025.